GSK and the Fleming Initiative have declared six new antimicrobial resistance (AMR) research programmes to help in reducing the increase of drug-resistant infections. The announcement follows the WHO GLASS report of October 2025 which estimates that
Merck reported fresh momentum for Winrevair, releasing positive topline data from its phase 2 CADENCE trial in adults with combined post- and precapillary pulmonary hypertension (CpcPH) due to heart failure with preserved ejection fraction (HFpEF)...
As the world observes World COPD Day on the third Wednesday of November, healthcare experts across India are calling for stronger public awareness of Chronic Obstructive Pulmonary Disease (COPD), a chronic and progressive lung condition that is...
Glenmark Pharmaceuticals has obtained marketing approval from the European Commission (EC) for Winlevi (clascoterone 10 mg/g cream), an innovative topical solution for acne, in 15 European nations
Birla Fertility & IVF, one of India’s fastest-growing fertility networks and part of the multibillion-dollar CKA Birla Group, today reaffirmed its commitment to transparency, ethical practices, and clinical excellence with the launch of its new...
.png "Zydus & SIG Unveil Innovative Single-Serve Cough Syrup Packaging")
Zydus Lifesciences and SIG have introduced a major advancement in pharmaceutical packaging with a single-serve format for liquid cough and cold medication. The launch leverages SIG’s tethered spout solution SIG StrawCap 30 Linked and Motion...
In a remarkable humanitarian initiative, the 14th edition of the free Plastic Surgery Camp, organized by Akums, in collaboration with Rotary International Club and Interplast Germany, has once again ignited hope among hundreds of underserved patients
.png "Lilly India Wins CDSCO Nod for Donanemab in Alzheimer's Care")
Eli Lilly and Company (India) Pvt. Ltd. has obtained CDSCO marketing approval for donanemab. The medication provides an alternative therapy to adults experiencing early symptomatic Alzheimer disease...
.png "Pfizer Launches Rimegepant to Strengthen Migraine Therapy")
Pfizer has introduced Rimegepant, a calcitonin gene-related peptide treatment for migraine, marking a notable expansion of its neuroscience portfolio in India. The company said the 75 mg orally disintegrating tablet is designed for adults who need...
WHO diabetes pregnancy guidelines published today are a significant change to the way the healthcare systems focus on a condition that occurs in one per six pregnancies across the globe. Approximately 21 million women are vulnerable to risks...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")